BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1399006)

  • 1. Role of the adhesion molecule lymphocyte function associated antigen 1 in toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human monocytes.
    See RH; Chow AW
    Infect Immun; 1992 Nov; 60(11):4957-60. PubMed ID: 1399006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes.
    See RH; Kum WW; Chang AH; Goh SH; Chow AW
    Infect Immun; 1992 Jul; 60(7):2612-8. PubMed ID: 1612731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors.
    See RH; Chow AW
    Infect Immun; 1992 Aug; 60(8):3456-9. PubMed ID: 1639516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1.
    Parsonnet J; Gillis ZA
    J Infect Dis; 1988 Nov; 158(5):1026-33. PubMed ID: 3263447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody.
    Pang LT; Kum WW; Chow AW
    Infect Immun; 2000 Jun; 68(6):3261-8. PubMed ID: 10816471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1.
    Kum WW; Laupland KB; See RH; Chow AW
    J Clin Microbiol; 1993 Oct; 31(10):2654-60. PubMed ID: 8253961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tumor necrosis factor alpha and interleukin-8 gene expression in bronchial epithelial cells by toxic shock syndrome toxin 1.
    Aubert V; Schneeberger D; Sauty A; Winter J; Sperisen P; Aubert JD; Spertini F
    Infect Immun; 2000 Jan; 68(1):120-4. PubMed ID: 10603377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells.
    Ikejima T; Okusawa S; van der Meer JW; Dinarello CA
    J Infect Dis; 1988 Nov; 158(5):1017-25. PubMed ID: 3263446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early activation events induced by the staphylococcal superantigen toxic shock syndrome toxin-1 in human peripheral blood monocytes.
    Trede NS; Morio T; Scholl PR; Geha RS; Chatila T
    Clin Immunol Immunopathol; 1994 Feb; 70(2):137-44. PubMed ID: 8299229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
    Mourad W; Scholl P; Diaz A; Geha R; Chatila T
    J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation of IL-1 beta and tumor necrosis factor-alpha genes by MHC class II ligands.
    Trede NS; Geha RS; Chatila T
    J Immunol; 1991 Apr; 146(7):2310-5. PubMed ID: 2005400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
    Kum WW; Hung RW; Cameron SB; Chow AW
    J Infect Dis; 2002 Feb; 185(4):555-60. PubMed ID: 11865410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1.
    Yokomizo Y; Mori Y; Shimoji Y; Shimizu S; Sentsui H; Kodama M; Igarashi H
    J Vet Med Sci; 1995 Apr; 57(2):299-305. PubMed ID: 7492650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tumour necrosis factor by staphylococcal toxic shock toxin 1.
    de Azavedo JC; Drumm A; Jupin C; Parant M; Alouf JE; Arbuthnott JP
    FEMS Microbiol Immunol; 1988 Jul; 1(2):69-74. PubMed ID: 3273461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
    J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.
    Parsonnet J; Hickman RK; Eardley DD; Pier GB
    J Infect Dis; 1985 Mar; 151(3):514-22. PubMed ID: 3871826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.
    Jupin C; Anderson S; Damais C; Alouf JE; Parant M
    J Exp Med; 1988 Mar; 167(3):752-61. PubMed ID: 3127526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
    Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
    Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW; Laupland KB; Chow AW
    Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells.
    Chatila T; Wood N; Parsonnet J; Geha RS
    J Immunol; 1988 Feb; 140(4):1250-5. PubMed ID: 2830336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.